These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25835138)

  • 1. In utero SSRI exposure and risk of clubfoot.
    Henriksen DP; Pottegård A; Jimenez-Solem E; Damkier P
    Epidemiology; 2015 May; 26(3):e34-5. PubMed ID: 25835138
    [No Abstract]   [Full Text] [Related]  

  • 2. The authors respond.
    Yazdy MM; Mitchell AA; Louik C; Werler MM
    Epidemiology; 2015 May; 26(3):e35-6. PubMed ID: 25835139
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of selective serotonin-reuptake inhibitors during pregnancy and the risk of clubfoot.
    Yazdy MM; Mitchell AA; Louik C; Werler MM
    Epidemiology; 2014 Nov; 25(6):859-65. PubMed ID: 25171134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
    Bérard A; Zhao JP; Sheehy O
    BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SSRI treatment during pregnancy: are we asking the right questions?
    Wisner KL
    Depress Anxiety; 2010 Aug; 27(8):695-8. PubMed ID: 20694964
    [No Abstract]   [Full Text] [Related]  

  • 6. Treating depression in pregnancy.
    Robert E
    N Engl J Med; 1996 Oct; 335(14):1056-8. PubMed ID: 8793933
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.
    Jordan S; Morris JK; Davies GI; Tucker D; Thayer DS; Luteijn JM; Morgan M; Garne E; Hansen AV; Klungsøyr K; Engeland A; Boyle B; Dolk H
    PLoS One; 2016; 11(12):e0165122. PubMed ID: 27906972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention-deficit/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study.
    Lupattelli A; Mahic M; Handal M; Ystrom E; Reichborn-Kjennerud T; Nordeng H
    BJOG; 2021 Nov; 128(12):1917-1927. PubMed ID: 33982858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonates born to mothers using antidepressant drugs.
    Zuccotti GV; Fabiano V; Manfredini V
    Early Hum Dev; 2012 May; 88 Suppl 2():S84-5. PubMed ID: 22633523
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of serotonin reuptake inhibitors in pregnancy.
    Malek-Ahmadi P
    Can J Psychiatry; 2000 Dec; 45(10):939-40. PubMed ID: 11190370
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitors and congenital malformations.
    Chambers C
    BMJ; 2009 Sep; 339():b3525. PubMed ID: 19776102
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of antidepressants in pregnancy: focus on maternal risks.
    Gadot Y; Koren G
    J Obstet Gynaecol Can; 2015 Jan; 37(1):56-63. PubMed ID: 25764038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SSRIs and birth defects.
    Kelly MB; Wisner KL; Cornelius MD
    Epidemiology; 2007 May; 18(3):411-2; author reply 412-3. PubMed ID: 17435454
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent trends in selective serotonin reuptake inhibitor use in pregnancy.
    Wichman CL; Fothergill A; Moore KM; Lang TR; Heise RH; Watson WJ
    J Clin Psychopharmacol; 2008 Dec; 28(6):714-6. PubMed ID: 19011450
    [No Abstract]   [Full Text] [Related]  

  • 15. SSRIs and birth defects.
    Burt V; Miller L; Einarson A
    Epidemiology; 2007 May; 18(3):410-1; author reply 412-3. PubMed ID: 17435452
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitors and the risk of congenital anomalies: a systematic review of current meta-analyses.
    Uguz F
    Expert Opin Drug Saf; 2020 Dec; 19(12):1595-1604. PubMed ID: 33001713
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of antidepressants during pregnancy].
    Pedersen LH; Videbech P
    Ugeskr Laeger; 2011 Apr; 173(15):1118-20. PubMed ID: 21672461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rock and a hard place: The selective serotonin reuptake inhibitor dilemmas in addressing perinatal mood and anxiety disorders.
    Stohl H; Kohm AD; Dossett E
    J Neonatal Perinatal Med; 2016; 9(1):1-5. PubMed ID: 27002264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case-control studies require appropriate population controls: an example of error in the SSRI birth defect literature.
    Bracken MB
    Eur J Epidemiol; 2015 Nov; 30(11):1217-8. PubMed ID: 26518772
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study.
    Wemakor A; Casson K; Garne E; Bakker M; Addor MC; Arriola L; Gatt M; Khoshnood B; Klungsoyr K; Nelen V; O'Mahoney M; Pierini A; Rissmann A; Tucker D; Boyle B; de Jong-van den Berg L; Dolk H
    Eur J Epidemiol; 2015 Nov; 30(11):1187-98. PubMed ID: 26148560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.